当前位置:首页 - 行情中心 - 恩威医药(301331) - 财务分析

恩威医药

(301331)

  

流通市值:8.74亿  总市值:26.67亿
流通股本:2298.28万   总股本:7013.84万

恩威医药(301331)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.08亿元,每股收益0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益107955.20万元,未分配利润36567.70万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产135553.74万元,负债27598.54万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入183,475,935.51785,191,289.82569,885,071.76395,248,359.56
营业总成本174,117,084.98698,325,008.56497,376,667.73332,471,371.23
营业利润10,492,562.26101,726,862.984,873,700.3874,000,366.06
利润总额10,491,990.31101,314,747.7685,131,636.8573,992,350.19
净利润8,423,929.9986,312,275.2172,934,990.1163,962,041.92
其他综合收益----
综合收益总额8,423,929.9986,312,275.2172,934,990.1163,962,041.92
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计796,383,809.55786,859,452.41884,410,593.17888,682,727.89
非流动资产合计559,153,562.74550,638,227.52434,019,808.1443,100,743.73
资产总计1,355,537,372.291,337,497,679.931,318,430,401.271,331,783,471.62
流动负债合计219,166,081.39209,773,105.66180,026,887.6201,735,660.23
非流动负债合计56,819,307.5324,538,667.8624,686,581.3825,303,827.29
负债合计275,985,388.92234,311,773.52204,713,468.98227,039,487.52
归属于母公司股东权益合计1,079,551,983.371,103,185,906.411,113,716,932.291,104,743,984.1
股东权益合计1,079,551,983.371,103,185,906.411,113,716,932.291,104,743,984.1
负债和股东权益合计1,355,537,372.291,337,497,679.931,318,430,401.271,331,783,471.62
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计171,252,786.05728,539,795.85547,985,308.34376,486,129.17
经营活动现金流出小计165,185,922.27644,528,729.29497,747,218.3346,691,497.05
经营活动产生的现金流量净额6,066,863.7884,011,066.5650,238,090.0429,794,632.12
投资活动现金流入小计218,362,194775,373,712.11569,370,213.6454,815,480.24
投资活动现金流出小计231,414,389.35819,549,298.58524,092,103.55385,379,865.87
投资活动产生的现金流量净额-13,052,195.35-44,175,586.4745,278,110.0569,435,614.37
筹资活动现金流入小计33,000,000---
筹资活动现金流出小计41,144,375145,221,774.4112,249,410.71112,249,410.71
筹资活动产生的现金流量净额-8,144,375-145,221,774.4-112,249,410.71-112,249,410.71
汇率变动对现金及现金等价物的影响10.49-28,083.72-27,919.69-27,880.42
现金及现金等价物净增加额-15,129,696.08-105,414,378.03-16,761,130.31-13,047,044.64
期末现金及现金等价物余额220,687,086.13235,816,782.21324,470,029.93328,184,115.6
TOP↑